BIOCRYST PHARMACEUTICALS, INC. Deferred Tax Assets, Property, Plant and Equipment
BIOCRYST PHARMACEUTICALS, INC. (BCRX) had Deferred Tax Assets, Property, Plant and Equipment of $1.05 million as of 2015-12-31, per its 10-K filed 2017-02-27.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment · last filed 2017-02-27
- 2015-12-31: Deferred Tax Assets, Property, Plant and Equipment $1.05M.
- 2014-12-31: Deferred Tax Assets, Property, Plant and Equipment $1.07M.
- 2013-12-31: Deferred Tax Assets, Property, Plant and Equipment $1.12M.
- 2012-12-31: Deferred Tax Assets, Property, Plant and Equipment $1.19M.
| Period end | Deferred Tax Assets, Property, Plant and Equipment |
|---|---|
| 2015-12-31 | $1.05M 10-K · filed 2017-02-27 |
| 2014-12-31 | $1.07M 10-K · filed 2016-02-26 |
| 2013-12-31 | $1.12M 10-K · filed 2015-03-02 |
| 2012-12-31 | $1.19M 10-K · filed 2014-03-10 |
| 2011-12-31 | $1.26M 10-K · filed 2013-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |